GeneWEAVE
Los Gatos · Founded 2010
About GeneWEAVE
GeneWeave Biosciences is advancing clinical microbiology with diagnostic solutions that will enable hospitals and physicians around the world to prevent drug-resistant infections, improve antibiotic stewardship and quickly determine the optimal antibiotic therapy for critical bacterial infections. The company’s innovative and proprietary Smarticles™ technology harnesses the power of biology to enable homogeneous assays that rapidly measure bacterial drug resistance without the need for enrichment, culture, or sample preparation.
Company Facts
- Founded: 2010
- Legal name: GeneWeave Biosciences, Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: M&A
- Last round: Series B (Jun 2014)
- Website: geneweave.com
- Phone: 607-379-0233
Social Profiles
Canonical: https://fsome.com/organization/geneweave-8401159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.